Change search
ReferencesLink to record
Permanent link

Direct link
Prioritising pharmaceuticals for environmental risk assessment: Towards adequate and feasible first-tier selection
Umeå University, Faculty of Science and Technology, Department of Chemistry.
Show others and affiliations
2012 (English)In: Science of the Total Environment, ISSN 0048-9697, E-ISSN 1879-1026, Vol. 421, 102-110 p.Article in journal (Refereed) Published
Abstract [en]

The presence of pharmaceuticals in the aquatic environment, and the concerns for negative effects on aquatic organisms, has gained increasing attention over the last years. As ecotoxicity data are lacking for most active pharmaceutical ingredients (APIs), it is important to identify strategies to prioritise APIs for ecotoxicity testing and environmental monitoring. We have used nine previously proposed prioritisation schemes, both risk- and hazard-based, to rank 582 APIs. The similarities and differences in overall ranking results and input data were compared. Moreover, we analysed how well the methods ranked seven relatively well-studied APIs. It is concluded that the hazard-based methods were more successful in correctly ranking the well-studied APIs, but the fish plasma model, which includes human pharmacological data, also showed a high success rate. The results of the analyses show that the input data availability vary significantly: some data, such as logP, are available for most API while information about environmental concentrations and bioconcentration are still scarce. The results also suggest that the exposure estimates in risk-based methods need to be improved and that the inclusion of effect measures at first-tier prioritisation might underestimate risks. It is proposed that in order to develop an adequate prioritisation scheme, improved data on exposure such as degradation and sewage treatment removal and bioconcentration ability should be further considered. The use of ATC codes may also be useful for the development of a prioritisation scheme that includes the mode of action of pharmaceuticals and, to some extent, mixture effects. (C) 2012 Elsevier B.V. All rights reserved.

Place, publisher, year, edition, pages
Amsterdam: Elsevier, 2012. Vol. 421, 102-110 p.
Keyword [en]
Pharmaceuticals, Environment, Risk assessment, Fish plasma model, Prioritisation, Ecotoxicity
National Category
Environmental Sciences
URN: urn:nbn:se:umu:diva-55528DOI: 10.1016/j.scitotenv.2012.01.039ISI: 000302832500011OAI: diva2:528622
Available from: 2012-05-28 Created: 2012-05-21 Last updated: 2012-05-28Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full text

Search in DiVA

By author/editor
Fick, Jerker
By organisation
Department of Chemistry
In the same journal
Science of the Total Environment
Environmental Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 142 hits
ReferencesLink to record
Permanent link

Direct link